Dr. Jagannath on Potential of Immunotherapy in Multiple Myeloma – OncLive
OncLive |
Dr. Jagannath on Potential of Immunotherapy in Multiple Myeloma
OncLive Immunotherapy approaches may overcome mutational burdens or drug resistance in the cancer cells of this disease, says Jagannath. Monoclonal antibodies such as daratumumab (Daralex) and elotuzumab (Empliciti) are being used in newly diagnosed … |
